Woodline Partners LP

Position in IBRX — ImmunityBio, Inc.

CIK 1784547 San Francisco, CA

Position in IBRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,441,143

+$19,616,994 QoQ

Shares Held

3,447,346

+0.0% QoQ

Ownership

0.329%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,423,987,323 across 188 Biotechnology names. IBRX ranks #40 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,441,143	3,447,346	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$6,824,149	3,446,540	-34.9%	Shares	Sole	2026-02-17
2025-09-30	$13,032,403	5,297,725	+53.7%	Shares	Sole	2025-11-14
2025-06-30	$9,097,099	3,445,871	+0.0%	Shares	Sole	2025-08-14
2025-03-31	$10,369,741	3,445,097	+0.1%	Shares	Sole	2025-05-15
2024-12-31	$8,812,646	3,442,440	+682.7%	Shares	Sole	2025-02-14
2024-09-30	$1,636,122	439,818	+0.5%	Shares	Sole	2024-11-14
2024-06-30	$2,767,167	437,843	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.